1049978-48-4

Basic information

• Product Name: 3,4,5-trimethoxyphenylbiguanide
• CAS NO: 1049978-48-4
• Molecular Weight: 267.288
• Mol File: 1049978-48-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3,4,5-trimethoxyphenylbiguanide(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,5-trimethoxyphenylbiguanide(1049978-48-4)
• EPA Substance Registry System: 3,4,5-trimethoxyphenylbiguanide(1049978-48-4)

Safety Data

• Hazardous Substances Data: 1049978-48-4(Hazardous Substances Data)

Upstream product

• 127099-85-8 N-Cyanoguanidine 
• 24313-88-0 3,4,5-Trimethoxyaniline 

Downstream Products

• 1448791-52-3 N-(2-(4-(trifluoromethyl)-6-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-ylamino)phenyl)acetamide 
• 1448791-51-2 1,1-dimethyl-3-(2-(4-methyl-6-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-ylamino)phenyl)urea 
• 1448791-50-1 methyl 2-(4-methyl-6-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-ylamino)phenylcarbamate 
• 1448791-49-8 N-(2-((4-methyl-6-((3,4,5-trimethoxyphenyl)amino)-1,3,5-triazin-2-yl)amino)phenyl)acetamide 
• 1448791-48-7 N-(2-(4-methyl-6-(3,4,5-trimethoxyphnylamino)-1,3,5-triazin-2-ylamino)phenyl)methanesulfonamide 
• 1374227-40-3 N-(2-nitrophenyl)-6-(trifluoromethyl)-N'-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine 
• 1374227-41-4 6-methyl-N-(2-nitrophenyl)-N'-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine 

Relevant articles and documents

High yielding microwave-assisted synthesis of tri-substituted 1,3,5-triazines using Pd-catalyzed aryl and heteroarylamination

A rapid and efficient Pd-catalyzed aryl and heteroarylamination under microwave irradiation has been developed for various tri-substituted triazines that can serve as versatile building blocks for both supramolecular and medicinal chemistry research. Particularly valuable features of this method included the short reaction time, good yield, and convenient operation.

Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity

We report herein the synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK (focal adhesion kinase) inhibitors and the evaluation of their anti-angiogenic activity on HUVEC cells. Generally, the effects of these compounds on endothelial cells co